Diurnal Group PLC - ESG Rating & Company Profile powered by AI
Browse to the end of this webpage for potential risks for Diurnal Group PLC based on sector, location and marketcap. This report of Diurnal Group PLC leverages information from across the internet as well as from public documents by Diurnal Group PLC. This Sustainability rating for Diurnal Group PLC represents the company's reporting of the United Nations SDGs.
Diurnal Group PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.7; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.0.
0.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1894 | Chongqing Zhifei Biological Products Co Ltd | 0.8 | Low |
| 1894 | Valens Company Inc | 0.8 | Low |
| 1898 | Diurnal Group PLC | 0.7 | Low |
| 1898 | CKD Bio Corp | 0.7 | Low |
| 1898 | Australis Capital Inc | 0.7 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Diurnal Group PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Diurnal Group PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Diurnal Group PLC report the average age of the workforce?
Sign up for free to unlockDoes Diurnal Group PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Diurnal Group PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Diurnal Group PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Diurnal Group PLC offer flexible work?
Sign up for free to unlockDoes Diurnal Group PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Diurnal Group PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Diurnal Group PLC conduct supply chain audits?
Sign up for free to unlockDoes Diurnal Group PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Diurnal Group PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Diurnal Group PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Diurnal Group PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Diurnal Group PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Diurnal Group PLC disclose water use targets?
Sign up for free to unlockDoes Diurnal Group PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Diurnal Group PLC have a product recall in the last two years?
Sign up for free to unlockDoes Diurnal Group PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Diurnal Group PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Diurnal Group PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Diurnal Group PLC disclose parental leave metrics?
Sign up for free to unlockDoes Diurnal Group PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Diurnal Group PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Diurnal Group PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Diurnal Group PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Diurnal Group PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Diurnal Group PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Diurnal Group PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Diurnal Group PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Diurnal Group PLC disclose its waste policy?
Sign up for free to unlockDoes Diurnal Group PLC report according to TCFD requirements?
Sign up for free to unlockDoes Diurnal Group PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Diurnal Group PLC disclose energy use targets?
Sign up for free to unlockDoes Diurnal Group PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Diurnal Group PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Diurnal Group PLC
These potential risks are based on the size, segment and geographies of the company.
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers an oral formulation of hydrocortisone granules in capsules for the treatment of pediatric adrenal insufficiency. It also develops Chronocort, which completed Phase II clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early-stage pipeline products comprise Ditest, a native oral testosterone product, which has completed phase I clinical trial for the treatment of classical hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (triiodothyronine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.